Identification of a Distinct Monocyte‐Driven Signature in Systemic Sclerosis Using Biophysical Phenotyping of Circulating Immune Cells
暂无分享,去创建一个
G. Schett | D. Soteriou | Markéta Kubánková | A. Matei | A. Györfi | Evgenia Boxberger | M. Kräter | Xuezhi Hong | Jörg H. Distler | Julia Prater | Liyan Xu | J. Guck | M. Papava | C. Bergmann
[1] G. Schett,et al. 68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study. , 2021, The Lancet. Rheumatology.
[2] J. Guck,et al. Physical phenotype of blood cells is altered in COVID-19 , 2021, bioRxiv.
[3] A. Antanaviciute,et al. Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma , 2021, Annals of the Rheumatic Diseases.
[4] S. Saidin,et al. Systemic Sclerosis Perturbs the Architecture of the Immunome , 2020, Frontiers in Immunology.
[5] J. Guck,et al. Intelligent image-based deformation-assisted cell sorting with molecular specificity , 2020, Nature Methods.
[6] W. Marut,et al. Novel insights into dendritic cells in the pathogenesis of systemic sclerosis , 2020, Clinical and experimental immunology.
[7] J. Guck,et al. The mechanics of myeloid cells , 2020, Biology of the cell.
[8] L. Kanz,et al. Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis , 2019, Arthritis Research & Therapy.
[9] M. Whitfield,et al. Shared and distinct mechanisms of fibrosis , 2019, Nature Reviews Rheumatology.
[10] S. Walsh,et al. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. , 2019, The New England journal of medicine.
[11] Madeleine K. D. Scott,et al. Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study , 2019, The Lancet. Respiratory medicine.
[12] L. Menschner,et al. Real‐time deformability cytometry reveals sequential contraction and expansion during neutrophil priming , 2019, Journal of leukocyte biology.
[13] P. Kuppen,et al. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile , 2019, Cancer Immunology, Immunotherapy.
[14] O. Distler,et al. Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis , 2019, Nature Reviews Rheumatology.
[15] David R. Myers,et al. The biophysics and mechanics of blood from a materials perspective , 2019, Nature Reviews Materials.
[16] Anna V. Taubenberger,et al. Spheroid Culture of Mesenchymal Stromal Cells Results in Morphorheological Properties Appropriate for Improved Microcirculation , 2019, Advanced science.
[17] M. Reynaud‐Gaubert,et al. Natural Killer Cells Exhibit a Peculiar Phenotypic Profile in Systemic Sclerosis and Are Potent Inducers of Endothelial Microparticles Release , 2018, Front. Immunol..
[18] Oliver Otto,et al. Real-time fluorescence and deformability cytometry , 2018, Nature Methods.
[19] J. Distler,et al. Targeting TGF-β signaling for the treatment of fibrosis. , 2018, Matrix biology : journal of the International Society for Matrix Biology.
[20] L. Menschner,et al. Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood , 2018, eLife.
[21] Anna V. Taubenberger,et al. Single-cell mechanical phenotype is an intrinsic marker of reprogramming and differentiation along the mouse neural lineage , 2017, Development.
[22] Sheng Yang Michael Loh,et al. Large‐scale image‐based screening and profiling of cellular phenotypes , 2017, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[23] M. Baron,et al. The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index , 2016, Annals of the rheumatic diseases.
[24] David R. Myers,et al. Cellular softening mediates leukocyte demargination and trafficking, thereby increasing clinical blood counts , 2016, Proceedings of the National Academy of Sciences.
[25] W. Marut,et al. Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment , 2015, Seminars in Immunopathology.
[26] Alain Richert,et al. Human Primary Immune Cells Exhibit Distinct Mechanical Properties that Are Modified by Inflammation. , 2015, Biophysical journal.
[27] U. Keyser,et al. Real-time deformability cytometry: on-the-fly cell mechanical phenotyping , 2015, Nature Methods.
[28] Jochen Guck,et al. Mechanics Meets Medicine , 2013, Science Translational Medicine.
[29] Yo Sup Moon,et al. Quantitative Diagnosis of Malignant Pleural Effusions by Single-Cell Mechanophenotyping , 2013, Science Translational Medicine.
[30] M. Hallett,et al. Ca2+ and calpain control membrane expansion during the rapid cell spreading of neutrophils , 2013, Journal of Cell Science.
[31] Yanfang Jiang,et al. Increased Numbers of NK Cells, NKT-Like Cells, and NK Inhibitory Receptors in Peripheral Blood of Patients with Chronic Obstructive Pulmonary Disease , 2013, Clinical & developmental immunology.
[32] M. Matucci-Cerinic,et al. Review: evidence that systemic sclerosis is a vascular disease. , 2013, Arthritis and rheumatism.
[33] D. Vergani,et al. CD14, CD16 and HLA‐DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA‐DR expression by CD14hi/CD16neg monocytes: Expansion of CD14hi/CD16pos and contraction of CD14lo/CD16pos monocytes in acute liver failure , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[34] Jochen Guck,et al. Viscoelastic Properties of Differentiating Blood Cells Are Fate- and Function-Dependent , 2012, PloS one.
[35] T. Hügle,et al. T cells in systemic sclerosis: a reappraisal. , 2012, Rheumatology.
[36] Dino Di Carlo,et al. A Mechanical Biomarker of Cell State in Medicine , 2012, Journal of laboratory automation.
[37] Miho Suzuki,et al. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. , 2012, Clinical science.
[38] P. Lachenbruch,et al. Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. , 2010, Arthritis and rheumatism.
[39] S. Jimenez,et al. As submitted to : Biomarkers in Medicine And later published as : “ Biomarkers in Systemic Sclerosis ” , 2017 .
[40] Daniel A. Fletcher,et al. Cell mechanics and the cytoskeleton , 2010, Nature.
[41] Stefan Schinkinger,et al. The regulatory role of cell mechanics for migration of differentiating myeloid cells , 2009, Proceedings of the National Academy of Sciences.
[42] C. Chizzolini. T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis , 2008, Current opinion in rheumatology.
[43] Daniel A Fletcher,et al. Analyzing cell mechanics in hematologic diseases with microfluidic biophysical flow cytometry. , 2008, Lab on a chip.
[44] D. Hansell,et al. Interstitial lung disease in systemic sclerosis: a simple staging system. , 2008, American journal of respiratory and critical care medicine.
[45] F Verrecchia,et al. [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.
[46] R. Kondo,et al. Neutrophil cytoskeletal rearrangements during capillary sequestration in bacterial pneumonia in rats. , 2006, American journal of respiratory and critical care medicine.
[47] Jochen Guck,et al. High-throughput single-cell mechanical phenotyping with real-time deformability cytometry. , 2018, Methods in cell biology.
[48] Oliver Otto,et al. Real-Time Deformability Cytometry: Label-Free Functional Characterization of Cells. , 2018, Methods in molecular biology.